Trials / Conditions / Gastric Neuroendocrine Carcinoma
Gastric Neuroendocrine Carcinoma
4 registered clinical trials studyying Gastric Neuroendocrine Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Clinical Study of Surufatinib Plus Sintilimab Combined With Chemotherapy in the Treatment of Advanced Gastric NCT06102746 | Tianjin Medical University Cancer Institute and Hospital | — |
| Active Not Recruiting | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors NCT02834013 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated ( NCT02595424 | ECOG-ACRIN Cancer Research Group | Phase 2 |
| Completed | the Optimal Surveillance Frequency for Patients With Gastric Neuroendocrine Carcinoma NCT05671393 | Fujian Medical University | — |